Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M279Revenue $M0Net Margin (%)0Z-Score
Enterprise Value $M279EPS $0Operating Margin %0F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)0Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %0Current Ratio0Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %ROA % (ttm)0Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)0Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M2.6ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with BBH

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found!

BBH is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


BBH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Kushniruk, David10% Security Holder, Director 2014-12-17Buy329,000$0.09127144.44view
Allen, JasonDirector, Senior Officer 2014-12-16Buy225,000$0.1481700view
O'Keeffe, William MichaelDirector 2014-12-16Buy100,000$0.1576246.67view
O'Keeffe, William MichaelDirector 2014-12-16Buy55,000$0.1576246.67view
O'Keeffe, William MichaelDirector 2014-12-16Buy500,000$0.1576246.67view
Lacoste, Jean-MarcDirector, Senior Officer 2014-12-16Buy15,500$0.1295333.33view
Lacoste, Jean-MarcDirector, Senior Officer 2014-12-16Buy12,500$0.1295333.33view
Lacoste, Jean-MarcDirector, Senior Officer 2014-12-16Buy2,000$0.1387992.31view
Sangha, Gurminder SinghDirector 2014-12-16Buy1,000$0.02572500view
mccartney, william davidDirector, Senior Officer 2014-12-16Buy0$0.4525348.89view

Press Releases about BBH :

    Quarterly/Annual Reports about BBH:

      News about BBH:

      Articles On GuruFocus.com
      No related article found.

      More From Other Websites
      Bio-Twitter Sentiment Favors European Orexigen Obesity Pill Approval Dec 17 2014
      Viekirax/Exviera vs. Harvoni: Clash of the Hep C Drugs 2015 Dec 16 2014
      Obesity Pill Upstart Orexigen Therapeutics Gaining on Rivals Dec 12 2014
      Biotech ETFs in Focus on Cubist Takeover Deal Dec 09 2014
      Merck Bid For Cubist Pharma Adds Fuel to Year's Best Biotech ETF Dec 08 2014
      The Dominance of Health Care ETFs in One Chart Nov 20 2014
      ETF Winners from Q3 Earnings Season Nov 11 2014
      Merger News Boosts ETFs Nov 03 2014
      Buy These Top Ranked ETFs on Solid Biotech Stock Earnings Oct 29 2014
      Finding The Best Biotech ETF Oct 29 2014
      A Biotech ETF Searches for New Highs Oct 27 2014
      Best And Worst ETFs Of The Week Amid Biotech Breakout Oct 24 2014
      Biotech ETFs Prescribe New ETFs Oct 23 2014
      [video] CDC needs to get ahead of Ebola: Cramer Oct 16 2014
      Biotech ETFs Aren’t Waving the White Flag…Yet Oct 15 2014
      [video] Market bright spots Oct 10 2014
      [video] Future of genetic testing Oct 07 2014
      The Zacks Analyst Blog Highlights: iShares Nasdaq Biotechnology ETF, SPDR S&P Biotech ETF, First... Oct 03 2014
      [video] Ebola stocks to watch Oct 01 2014
      In a Tricky Year for Momentum, This ETF Finds Success Sep 24 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK